WASHINGTON (February 3) - As part of its ongoing investigation into the
safety of prescription drugs, Rep. James Greenwood (R-PA), Chairman of the House
Energy and Commerce Subcommittee on Oversight and Investigations, sent letters
to four drug manufacturers seeking data and background information on
unpublished clinical trials involving depressed children.
Identical letters were sent February 3 to:
Wyeth
Pharmaceuticals President Bernard Poussot,
Eli
Lilly & Company Chairman Sidney Taurel;
GlaxoSmithKline
President Christopher Viehbacher; and,
Pfizer
Chairman and CEO Dr. Hank McKinnell, Ph.D.)
